Soleno Therapeutics had a revenue of 94.60M in the quarter ending Mar 31, 2026, with 3.13%. This bring the company's revenue in the last twelve months to 285.01M, Decreased 49.69%. In the fiscal year ending Dec 31, 2025, Soleno Therapeutics had annual revenue of 190.41M with Infinity% growth.